Michelle Morcos-Sandino

Dr. Michelle Morcos-Sandino

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 May 2025 in Biomedicines
Verified
Journal Article
Open access
MMMichelle Morcos-Sandino
Michelle Morcos-Sandino
Sofia Isabel Quezada-RamirezSofia Isabel Quezada-Ramirez
Sofia Isabel Quezada-Ramirez
ALAndrés Gómez-De León
Andrés Gómez-De León
Acute myeloid leukemia (AML) presents a significant global health challenge due to its aggressive behavior and mortality rates. Traditionally, AML treatment has relied on intensive chemotherapy—anthracyclines and cytarabine. However, recent breakthroughs in targeted therapies are transforming clinical practices. This review examines current treatment strategies, including breakthrough therapies. Also, a global perspective on AML management includes the disparity in treatment availability, particularly the difficulties faced by low- and middle-income countries due to the high cost and restricted access to novel therapies.

14 August 2020 in British Journal of Haematology
Verified
Journal Article
Closed access
PDF file
CPCésar Pezina‐Cantú
César Pezina‐Cantú
ALAndrés Gómez-De León
Andrés Gómez-De León
JJJosé C. Jaime‐Perez
José C. Jaime‐Perez
PCPerla Colunga‐Pedraza
Perla Colunga‐Pedraza
LTLuz Tarín‐Arzaga
Luz Tarín‐Arzaga
DGDavid Gómez‐Almaguer
David Gómez‐Almaguer